Abstract
Titanium dioxide nanoparticles (TiO2 NPs) were used as an effective catalyst in the solvent-free, one-pot threecomponent reaction of aromatic aldehydes, malononitrile and 4-hydroxycoumarin to produce corresponding dihydropyrano[ c]chromenes in high yields. This method has the advantages of a simple operation, short reaction time, high yields, easy work-up, reusability of the catalyst, and an environmentally friendly specificity.
Keywords: Dihydropyrano[c]chromenes, Domino Knoevenagel-Michael addition, Solvent-free, TiO2 nanoparticles.
Current Catalysis
Title:Solvent-Free Synthesis of 4,5-Dihydropyrano[c]chromene Derivatives Over TiO2 Nanoparticles as an Economical and Efficient Catalyst
Volume: 2 Issue: 2
Author(s): Shahrzad Abdolmohammadi
Affiliation:
Keywords: Dihydropyrano[c]chromenes, Domino Knoevenagel-Michael addition, Solvent-free, TiO2 nanoparticles.
Abstract: Titanium dioxide nanoparticles (TiO2 NPs) were used as an effective catalyst in the solvent-free, one-pot threecomponent reaction of aromatic aldehydes, malononitrile and 4-hydroxycoumarin to produce corresponding dihydropyrano[ c]chromenes in high yields. This method has the advantages of a simple operation, short reaction time, high yields, easy work-up, reusability of the catalyst, and an environmentally friendly specificity.
Export Options
About this article
Cite this article as:
Abdolmohammadi Shahrzad, Solvent-Free Synthesis of 4,5-Dihydropyrano[c]chromene Derivatives Over TiO2 Nanoparticles as an Economical and Efficient Catalyst, Current Catalysis 2013; 2 (2) . https://dx.doi.org/10.2174/2211544711302020005
DOI https://dx.doi.org/10.2174/2211544711302020005 |
Print ISSN 2211-5447 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5455 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Syntheses of Ethyl Pyruvate’s Bioisosteres Inhibiting Inducible Nitric Oxide Production in Lipopolysaccharide-induced BV2 Cells
Letters in Drug Design & Discovery Noscapine and its Analogs as Chemotherapeutic Agent: Current updates
Current Topics in Medicinal Chemistry New Challenges in CNS Repair: The Immune and Nervous Connection
Current Immunology Reviews (Discontinued) Progress in Multiple Sclerosis Genetics
Current Genomics Lymphocytes in Alzheimer’s Disease Pathology: Altered Signaling Pathways
Current Alzheimer Research Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease
Current Alzheimer Research Potential of Photobiomodulation to Induce Differentiation of Adipose- Derived Mesenchymal Stem Cells into Neural Cells
Current Stem Cell Research & Therapy Editorial [Hot topic: Transgenic Animal Models of Neurodegenerative Diseases (Guest Editor: Stephen D. Skaper)]
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Mitochondria as a Pharmacological Target: A Clue for Efficacy and a Reason for Toxicity (Executive Guest Editor: Nadezda Apostolova)]
Current Pharmaceutical Design Skeletal Muscle in Motor Neuron Diseases: Therapeutic Target and Delivery Route for Potential Treatments
Current Drug Targets Editorial [Hot Topic:Role of Neural Stem Cells in Neurodegenerative Diseases:From the Molecule and Cell to the Clinic (Guest Editor: Oscar Gonzalez-Perez)]
Current Signal Transduction Therapy Glaucoma and Aging
Current Aging Science Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Insights on the Neuromodulatory Propensity of Selaginella (Sanjeevani) and its Potential Pharmacological Applications
CNS & Neurological Disorders - Drug Targets Proteasome Inhibition: A Promising Strategy for Treating Cancer, but What About Neurotoxicity?
Current Medicinal Chemistry Expression and Function of the Endocannabinoid System in Glial Cells
Current Pharmaceutical Design Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells
Recent Patents on Regenerative Medicine MicroRNA in Implant Dentistry: From Basic Science to Clinical Application
MicroRNA Personalized Drug Discovery: HCA Approach Optimized for Rare Diseases at Tel Aviv University
Combinatorial Chemistry & High Throughput Screening Role of Antioxidants in Redox Regulation of Diabetic Cardiovascular Complications
Current Pharmaceutical Biotechnology